Adult attention deficit/hyperactivity disorder among the prison inmates: An investigation of the executive function differences and comorbidity effects-Reference-Cited by-同舟云学术

Adult attention deficit/hyperactivity disorder among the prison inmates: An investigation of the executive function differences and comorbidity effects

Published:2018-09-01 Issue:3 Volume:70 Page:235-245
ISSN:0004-9530
Container-title:Australian Journal of Psychology
language:en
Short-container-title:Australian Journal of Psychology

Author:

Hamzeloo Mohammad¹,Mashhadi Ali²,Fadardi Javad S.²³⁴,Ghahremanzadeh Melika²

Affiliation:

1. Research Center of Gorgan Prison, Gorgan, Iran,

2. Department of Psychology, Ferdowsi University of Mashhad, Mashhad, Iran,

3. School of Psychology, Bangor University, Bangor, Wales, UK,

4. School of Community and Global Health, Claremont Graduate University, Claremont, California, USA,

Publisher

Informa UK Limited

Subject

General Psychology

Link

https://www.tandfonline.com/doi/pdf/10.1111/ajpy.12201

Reference72 articles.

1. Attention-deficit/hyperactivity disorder (ADHD) and working memory in adults: A meta-analytic review.

2. Diagnostic and Statistical Manual of Mental Disorders

3. Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD.

4. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing Inhibitory Control Deficits in Adult ADHD: A Systematic Review and Meta-analysis of the Stop-signal Task;Neuropsychology Review;2023-06-10

2. Emotion control training enhances reappraisal success among individuals with reported ADHD symptoms;Scientific Reports;2022-08-18

3. Assessing inhibitory control deficits in adult ADHD: A systematic review and meta-analysis of the stop-signal task;2022-07-10

4. Violent offending in borderline personality disorder and attention deficit/hyperactivity disorder;Neuropharmacology;2019-09